ArticleExperimental biology and medicine (Maywood, N.J.)2024

A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms.

Nahid Zareian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.